#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Athero Review - Issue 1/2020

Editorial

3

Guidelines

8

Homocysteine consensus

Ján Lietava, Pavel Blažíček, Martin Čaprnda, Katarína Rašlová, Jana Tisoňová, Branislav Vohnout

16

Comments on the new recommendations for dyslipidemia and cardiovascular risk management with regard to diabetes mellitus

Branislav Vohnout, Rid Bugáňová

22

Hypercholesterolemia as a risk factor for hearing loss: Do we have sufficient evidence?

Zuzana Capová, Lukáš Varga

27

Uric acid and influence of hyperuricaemia therapy on prevention of atheroscleroris and cardiovascular diseases

Ubica Cibičková, Martin Žurek

33

Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents

Jan Škrha Jr

37

Pitfalls of diet therapy in dyslipidemias

Věra Boháčová, Tamara Starnovská

clinical studies

43

ASCOT Legacy: the first long-term monitoring of the effect of antihypertensive treatment combined with statin on mortality

Michal Vrablík

47

Characteristics of patients with uncontrolled arterial hypertension and/or dyslipidemia in primary care in Czechia– LipitenCliDec Study: 1^st phase results

Martin Šatný, Jana Mašková, Eva Tůmová, Jiří Laštůvka, Michal Vrablík

55

Horúce novinky zo štúdie ODYSSEY OUTCOMES (kongres American Heart Association november 2019)

Ján Murín

From International Literature

60

Rešerše zajímavých článků ze zahraniční literatury

Eva Tůmová

Annoucements

63

Zprávy z odborných akcí ČSAT

Kristýna Čillíková

Athero Review

Issue 1

2020 Issue 1

Most read in this issue

#ADS_BOTTOM_SCRIPTS#